Kopelman PG - Search Results

1

Kopelman PG. Kopelman PG. Br J Hosp Med (Lond). 2007 Feb;68(2):89-93. doi: 10.12968/hmed.2007.68.2.22828. Br J Hosp Med (Lond). 2007. PMID: 17370714 Review.

2

Management of obesity: improvement of health-care training and systems for prevention and care.

Dietz WH, Baur LA, Hall K, Puhl RM, Taveras EM, Uauy R, Kopelman P. Dietz WH, et al. Lancet. 2015 Jun 20;385(9986):2521-33. doi: 10.1016/S0140-6736(14)61748-7. Epub 2015 Feb 19. Lancet. 2015. PMID: 25703112 Review.

3

Health risks associated with overweight and obesity.

Kopelman P. Kopelman P. Obes Rev. 2007 Mar;8 Suppl 1:13-7. doi: 10.1111/j.1467-789X.2007.00311.x. Obes Rev. 2007. PMID: 17316295 Review. No abstract available.

4

Prescribing for obesity. Comment on the Royal College of Physicians' Working Party report on clinical management of overweight and obese patients with particular reference to drugs.

Kopelman P. Kopelman P. J R Coll Physicians Lond. 1999 Jan-Feb;33(1):31-2. J R Coll Physicians Lond. 1999. PMID: 10192066 Free PMC article.

5

Emerging management strategies for obesity.

Kopelman PG. Kopelman PG. Int J Obes Relat Metab Disord. 1998 Aug;22 Suppl 1:S7-11; discussion S12, S42. Int J Obes Relat Metab Disord. 1998. PMID: 9758238 Review.

6

Cetilistat (ATL-962), a novel lipase inhibitor: a 12-week randomized, placebo-controlled study of weight reduction in obese patients.

Kopelman P, Bryson A, Hickling R, Rissanen A, Rossner S, Toubro S, Valensi P. Kopelman P, et al. Int J Obes (Lond). 2007 Mar;31(3):494-9. doi: 10.1038/sj.ijo.0803446. Epub 2006 Sep 5. Int J Obes (Lond). 2007. PMID: 16953261 Clinical Trial.

7

Clinical treatment of obesity: are drugs and surgery the answer?

Kopelman PG. Kopelman PG. Proc Nutr Soc. 2005 Feb;64(1):65-71. doi: 10.1079/pns2004410. Proc Nutr Soc. 2005. PMID: 15877924 Free article.

8

Options for the management of obesity.

Beales PL, Kopelman PG. Beales PL, et al. Among authors: kopelman pg. Pharmacoeconomics. 1994;5(Suppl 1):18-32. doi: 10.2165/00019053-199400051-00005. Pharmacoeconomics. 1994. PMID: 10147245 Review.

9

Leisure-time activity is an important determinant of long-term weight maintenance after weight loss in the Sibutramine Trial on Obesity Reduction and Maintenance (STORM trial).

van Baak MA, van Mil E, Astrup AV, Finer N, Van Gaal LF, Hilsted J, Kopelman PG, Rössner S, James WP, Saris WH; STORM Study Group. van Baak MA, et al. Among authors: kopelman pg. Am J Clin Nutr. 2003 Aug;78(2):209-14. doi: 10.1093/ajcn/78.2.209. Am J Clin Nutr. 2003. PMID: 12885699 Clinical Trial.

10

Effect of sibutramine on weight maintenance after weight loss: a randomised trial. STORM Study Group. Sibutramine Trial of Obesity Reduction and Maintenance.

James WP, Astrup A, Finer N, Hilsted J, Kopelman P, Rössner S, Saris WH, Van Gaal LF. James WP, et al. Lancet. 2000 Dec 23-30;356(9248):2119-25. doi: 10.1016/s0140-6736(00)03491-7. Lancet. 2000. PMID: 11191537 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118 results

Search Page

Filters